| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/21/1993 | WO1993000888A1 Loading technique for preparing drug containing liposomes |
| 01/21/1993 | WO1993000873A1 Composition and method for transdermal delivery of diclofenac |
| 01/21/1993 | WO1993000813A1 Germicidal compositions containing iodated compounds |
| 01/21/1993 | WO1992020337A3 Inhibition of metastasis in patients having cancer with pyridyloxazole-2-ones |
| 01/21/1993 | WO1992019212A3 Glycine anhydride dimethylol as a biocide and preservative |
| 01/21/1993 | WO1992019211A3 Imidazobenzoquinones and composition for preventing or treating hypertension or congestive heart failure containing the same |
| 01/21/1993 | WO1992008450A3 Antiviral use of a 2,6-di-t-butylphenol compound substituted in position 4, particularly in relation to herpesviruses and papillomaviruses |
| 01/21/1993 | DE4223438A1 Cyclische oligonucleotidphosphorthioate Cyclic oligonucleotidphosphorthioate |
| 01/21/1993 | DE4123914A1 Use of 3-isopropyl carbamyl sulphonamido-4- (3-methylphenyl) amino-pyridine - for treatment of obstructive airway disorders, e.g. acute or chronic bronchitis or asthma |
| 01/21/1993 | DE4123520A1 Use of nucleoside derivs. e.g. 5'-deoxy:arabinosyl:cytosine - for promoting leukocyte proliferation in treatment of leukopenia |
| 01/21/1993 | DE4122497A1 Treatment of inflammatory skin diseases with cis-urocanic acid - formed by UV irradiation of trans-isomer, on skin or in vitro, esp. for psoriasis |
| 01/21/1993 | CA2113164A1 Pharmaceutical composition for peritoneal dialysis |
| 01/21/1993 | CA2113163A1 Metabolizable plasma substitute |
| 01/21/1993 | CA2112803A1 Antiviral liponucleosides: treatment of hepatitis b |
| 01/21/1993 | CA2112799A1 Method and assay system for neurotrophin activity |
| 01/21/1993 | CA2112751A1 Composition and method for transdermal delivery of diclofenac |
| 01/21/1993 | CA2112744A1 Hydroisoquinoline derivatives |
| 01/21/1993 | CA2112378A1 Analgesic preparation |
| 01/21/1993 | CA2111710A1 Dibenz[b,e]azepin derivatives and medicaments containing these |
| 01/21/1993 | CA2111593A1 Loading technique for preparing drug containing liposomes |
| 01/21/1993 | CA2111345A1 Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients |
| 01/21/1993 | CA2110986A1 Cholecystokinin antagonists useful in the treatment of panic attacks |
| 01/21/1993 | CA2110725A1 Aromatic compounds, compositions containing them and their use in therapy |
| 01/21/1993 | CA2110514A1 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/21/1993 | CA2110513A1 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/21/1993 | CA2110167A1 Pyrazolopyrimidine and pyrimidinyl bisphosphonic esters as anti-inflammatories |
| 01/21/1993 | CA2090876A1 Apoptosis regulating composition |
| 01/20/1993 | WO1993002096A1 PROCESS FOR THE PREPARATION OF 17β-SUBSTITUTED-4-AZA-5α-ANDROSTAN-3-ONE DERIVATIVES |
| 01/20/1993 | WO1993002037A1 Arylamidoalkyl-n-hydroxyurea compounds having lipoxygenase inhibitory activity |
| 01/20/1993 | EP0524161A1 Manganese complexes of nitrogen containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 01/20/1993 | EP0524146A1 Aminosubstituted Piperazinederivatives |
| 01/20/1993 | EP0524055A1 Imidazo(2,1-b)benzothiazole-3-acetamide derivatives, process for their preparation and their therapeutical use |
| 01/20/1993 | EP0524023A1 Trifluoromethylbenzylphosphonates useful in treating osteoporosis |
| 01/20/1993 | EP0524004A1 Decahydro-8H-isoquino[2,1-g][1,6]naphthyridine and decahydrobenzo[a]pyrrolo[2,3-e]quinolizine derivatives |
| 01/20/1993 | EP0523846A2 1,4-Benzodiazepines with 5-membered heterocyclic rings |
| 01/20/1993 | EP0523845A2 New benzodiazepine analogs |
| 01/20/1993 | EP0523803A1 1,2,4-Oxadiazolyl-phenoxy-alkylisoxazoles and their use as antiviral agents |
| 01/20/1993 | EP0523688A1 Process for the preparation of 17beta-substituted-4-aza-5alpha-androstan-3-one derivatives |
| 01/20/1993 | EP0523555A1 Pharmaceutical composition useful in inhibiting biological degradation of polymeric implantation material |
| 01/20/1993 | EP0523529A2 Anticoccidial compositions |
| 01/20/1993 | EP0523523A1 Anticoccidial compositions |
| 01/20/1993 | EP0523513A1 Use of substituted pyridazines for the treatment of dermatoses |
| 01/20/1993 | EP0523512A1 8-vinyl- and 8-ethinyl-quinolone carboxylic acids |
| 01/20/1993 | EP0523499A1 Acetohydroxamic acid compound, medicaments containing it and method for the preparation of this compound and the medicaments |
| 01/20/1993 | EP0523493A1 Dithianes |
| 01/20/1993 | EP0523189A1 Cationic lipids for intracellular delivery of biologically active molecules |
| 01/20/1993 | EP0523160A1 Carbo-nucleoside derivatives |
| 01/20/1993 | EP0523150A1 Device and method for enhanced administration of physostigmine |
| 01/20/1993 | EP0523141A1 Substituted pyrazoles, isoxazoles and isothiazoles |
| 01/20/1993 | EP0523138A1 Novel derivatives of phenyl-cycloalkanes and -cycloalkenes |
| 01/20/1993 | EP0523131A1 High molecular weight polyvinylpyrrolidones and method for their preparation |
| 01/20/1993 | EP0523110A1 Nucleoside derivatives |
| 01/20/1993 | EP0523086A1 Pharmaceutical aqueous solution of 4- 2-(benzolsulphonylamino)-ethyl]-phenoxyacetic acid |
| 01/20/1993 | EP0523046A1 2-anilino phenylacetic acid derivatives as inhibitors of pla 2? and lipoxygenase |
| 01/20/1993 | EP0523037A1 Fluid resuscitation |
| 01/20/1993 | EP0396634B1 Method for treating xerostomia employing chewing gum |
| 01/20/1993 | EP0377658B1 A free-flowing granular composition containing ibuprofen and a method for its preparation |
| 01/20/1993 | EP0278008B1 Taurine type compounds |
| 01/20/1993 | EP0257086B1 Skinpenetration enhancing compositions |
| 01/20/1993 | EP0236477B1 Use of 6-methylene-6-desoxy-n-cyclopropylmethyl-14-hydroxydihydronormorphine |
| 01/20/1993 | CN1068119A Octadecyl(2-(n-methyl-priperidino)-ethyl)-phosphate and process for its preparation |
| 01/20/1993 | CN1068118A Imidazo(2,1-b)(3) benzazeping derivatives, compositions and method of use |
| 01/20/1993 | CN1068117A Heterocyclic compounds with renin-inhibiting properties, process for preparation thereof and use thereof |
| 01/20/1993 | CN1068116A Imidazo(1,2-a)(pyrrolo, thieno or furano)(3,2-d)azepine derivatives, compositions and methods of use |
| 01/20/1993 | CN1068115A 7-isoindolinyl-quinolone-and-naphthyridone carboxylic acid herivatives |
| 01/20/1993 | CN1068114A 7-azaisoindolinyl-quinolone-and-naphthyridonecarboxylic acid derivatives |
| 01/20/1993 | CN1068113A Preparation of tetrahydropalmatinum by using guaiacol as material |
| 01/20/1993 | CN1068112A Compounds with renin-inhibiting properties, process for the preparation thereof and use thereof |
| 01/20/1993 | CN1068111A Derivatives of (hetero) aromatic ethers and thioethers process for preparing same and pharmaceutical composition containing them |
| 01/20/1993 | CN1068109A Novel angiotensin ii antagonists and p paring and applying formulation of thereof |
| 01/20/1993 | CN1068035A Abrogation of uiral resistance to nucleoside analogues by double-stranded rnas |
| 01/20/1993 | CN1068034A Methods of using lysophosphatidic acids for regulating skin wrinkles |
| 01/20/1993 | CN1068033A Method and composition for ameliorating adverse effects of aging |
| 01/20/1993 | CA2102122A1 Arylamidoalkyl-n-hydroxyurea compounds having lipoxygenase inhibitory activity |
| 01/20/1993 | CA2091983A1 Process for the preparation of 17.beta.-substituted-4-aza-5.alpha.-androstan-3-one derivatives |
| 01/20/1993 | CA2074154A1 Amino-substituted piperazine derivatives |
| 01/20/1993 | CA2074112A1 Imidazo[2,1-b]benzothiazole-3-acetamide derivatives, their preparation and their use in therapeutics |
| 01/20/1993 | CA2073993A1 8-vinyl- and 8-ethinyl-quinolone-carboxylic acids |
| 01/20/1993 | CA2072897A1 Manganese (ii) complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 01/19/1993 | US5180850 Crystalline magnesium valporate and a method for the preparation thereof |
| 01/19/1993 | US5180837 Pilosinine derivatives |
| 01/19/1993 | US5180748 Avarone and its pharmaceutical compositions and use as an antiviral agent |
| 01/19/1993 | US5180746 Aralkylamine compounds |
| 01/19/1993 | US5180745 Method for providing a neuroprotective effect |
| 01/19/1993 | US5180742 Lipoxygenase Inhibitors |
| 01/19/1993 | US5180741 Pyrethrinoid esters carrying an indanyl nucleus and their use as pesticides |
| 01/19/1993 | US5180739 Use of 3-oxygermylpropionic acid to treat and prevent diabetes-dependent type of autoimmune diseases |
| 01/19/1993 | US5180738 Angiogenesis Inhibitors |
| 01/19/1993 | US5180733 Biogenic amine uptake inhibitors |
| 01/19/1993 | US5180729 Use of sigma receptor antagonists for treatment of cocaine abuse |
| 01/19/1993 | US5180728 Pyrimidoindole derivatives and processes for preparation thereof |
| 01/19/1993 | US5180726 Preventing Neurotic, Depressive or Psychotic Behavior |
| 01/19/1993 | US5180723 Certain sulfonamide heterobicyclic platelet activating factor antagonists |
| 01/19/1993 | US5180721 Imidazoline substituted naphthalene compounds for treatment of glaucoma |
| 01/19/1993 | US5180715 Treatment of bladder infections, cystitis |
| 01/19/1993 | US5180714 Adenosine compounds for the treatment of diseases caused by parasitic protozoa |
| 01/19/1993 | US5180590 Mixture with sodium salt, sodium bicarbonate and citric acid |
| 01/19/1993 | US5180589 Pravastatin pharmaceuatical compositions having good stability |
| 01/19/1993 | US5180588 Dioxabicyclo 3.3.0!octane derivatives and enzyme transferases |
| 01/19/1993 | CA2074062A1 Dithiane |